LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.

    Akyala, Adamu Ishaku / Awayimbo, Jaggu Ruth / Ogo, Anowai Clementina / Chima, Ndubuisi John / Billyrose, Olusoji Mathew Adeyemi / Engom, Alaba Ovye Godiya

    The Pan African medical journal

    2021  Volume 39, Page(s) 3

    Abstract: ... from health care workers who tested positive PCR for SARS-CoV-2 with symptoms consistent with SARS-CoV-2 receiving ... health care workers who tested negative PCR for SARS-CoV-2 with no symptoms to SARS-CoV-2. The median ... antibody assays in Nigeria and so we evaluated the diagnostic performance of five (5) immunoassay on a set ...

    Abstract While molecular techniques remain the gold standard for diagnosis of acute SARS-CoV-2 infection, serological tests have the unique potential to ascertain how much of the population has been exposed to the COVID-19 pathogen. There have been limited published studies to date documenting the performance of SARS-CoV-2 antibody assays in Nigeria and so we evaluated the diagnostic performance of five (5) immunoassay on a set of clinical samples. Five automated immunoassays (2019-nCoV IgG/IgM antibody determination kit, Tigsun COVID-19 combo IgM/IgG rapid test, rapid response COVID-19 IgG/IgM test, COVID-19 IgM-IgG combined antibody rapid test, iChroma COVID-19 Ab) were tested. Three hundred and fourteen specimens were analyzed from health care workers who tested positive PCR for SARS-CoV-2 with symptoms consistent with SARS-CoV-2 receiving treatment at two treatment centres in Nasarawa State from March to September, 2020 with control of 134 health care workers who tested negative PCR for SARS-CoV-2 with no symptoms to SARS-CoV-2. The median patients' age was 40 years (IQR 39.8-41), majority were male and were on admission. The SARS-CoV-2 IgG/IgM antibody evaluated kits had a sensitivity of 33% (2019-nCoV IgG/IgM antibody determination kit), 22% (Tigsun COVID-19 combo IgM/IgG rapid test), 43% (rapid response COVID-19 IgG/IgM test), 44% (COVID-19 IgM-IgG combined antibody rapid test), 25% (iChroma COVID-19 Ab), 100% sensitivity, accuracy of 68.5% and Kappa coefficient of 0.7 and rapid response COVID-19 IgG/IgM test cassette had a sensitivity of 33%, specificity of 100% and accuracy of 72.5% with Kappa coefficient 0.7. The Tigsun COVID-19 combo IgM/IgG rapid test (lateral flow), positive, COVID-19 IgM-IgG combined antibody rapid test and iChroma COVID-19 Ab RT all had sensitivity of zero percent. Serology was complementary to RT-PCR for the diagnosis of COVID-19 at least 14 days after onset of symptoms. The assay panel needs to be improved to serve as an option for the diagnosis of SARS-CoV-2 in resource constrained settings where there are limited molecular diagnostics testing panels.
    MeSH term(s) Adult ; Antibodies, Viral/blood ; COVID-19/diagnosis ; COVID-19/immunology ; COVID-19 Testing/methods ; Female ; Humans ; Immunoassay/methods ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Nigeria ; SARS-CoV-2/immunology ; SARS-CoV-2/isolation & purification ; Sensitivity and Specificity ; Serologic Tests/methods
    Chemical Substances Antibodies, Viral ; Immunoglobulin G ; Immunoglobulin M
    Language English
    Publishing date 2021-05-03
    Publishing country Uganda
    Document type Comparative Study ; Journal Article ; Multicenter Study
    ZDB-ID 2514347-5
    ISSN 1937-8688 ; 1937-8688
    ISSN (online) 1937-8688
    ISSN 1937-8688
    DOI 10.11604/pamj.2021.39.3.26471
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting

    Adamu Ishaku Akyala / Jaggu Ruth Awayimbo / Anowai Clementina Ogo / Ndubuisi John Chima / Olusoji Mathew Adeyemi Billyrose / Alaba Ovye Godiya Engom

    The Pan African Medical Journal, Vol 39, Iss

    2021  Volume 3

    Abstract: ... antibody assays in Nigeria and so we evaluated the diagnostic performance of five (5) immunoassay on a set ... of clinical samples . Five automated immunoassays (2019-nCoV IgG/IgM Antibody Determination Kit, Tigsun COVID ... While molecular techniques remain the gold standard for diagnosis of acute SARS-CoV-2 infection ...

    Abstract While molecular techniques remain the gold standard for diagnosis of acute SARS-CoV-2 infection, serological tests have the unique potential to ascertain how much of the population has been exposed to the COVID-19 pathogen. There have been limited published studies to date documenting the performance of SARS-CoV-2 antibody assays in Nigeria and so we evaluated the diagnostic performance of five (5) immunoassay on a set of clinical samples . Five automated immunoassays (2019-nCoV IgG/IgM Antibody Determination Kit, Tigsun COVID-19 Combo IgM/IgG Rapid Test, Rapid Response COVID-19 IgG/IgM Test, COVID-19 IgM-IgG Combined Antibody Rapid Test, iChroma COVID-19 Ab) were tested. 314 specimens were analyzed from Health care workers who tested positive PCR for SARS-CoV-2 with symptoms consistent with SARS-CoV-2 receiving treatment at two treatment centres in Nasarawa State from March to September, 2020 with control of 134 Health care workers who tested negative PCR for SARS-CoV-2 with no symptoms to SARS-CoV-2. .The median patients’ age was 40 years (IQR 39·8–41), majority were male, and were on admission. The SARS-CoV-2 IgG/IgM Antibody evaluated Kits had a sensitivity of 33% (2019-nCoV IgG/IgM Antibody Determination Kit), 22%( Tigsun COVID-19 Combo IgM/IgG Rapid Test), 43% (Rapid Response COVID-19 IgG/IgM Test), 44% (COVID-19 IgM-IgG Combined Antibody Rapid Test), 25%( iChroma COVID-19 Ab), 100% sensitivity, accuracy of 68.5% and Kappa Coefficient of 0.7 and Rapid Response COVID-19 IgG/IgM Test Cassette had a sensitivity of 33%, specificity of 100% and accuracy of 72.5% with Kappa Coefficient 0.7. The Tigsun COVID-19 Combo IgM/IgG Rapid Test (lateral flow), Positive, COVID-19 IgM-IgG Combined Antibody Rapid Test and iChroma COVID-19 Ab RTall had sensitivity of zero percent. Serology was complementary to RT-PCR for the diagnosis of COVID-19 at least 14 days after onset of symptoms. The assay panel needs to be improved to serve as an option for the diagnosis of SARS-CoV-2 in resource constrained settings where there are ...
    Keywords coronavirus ; diagnosis ; rapid diagnostic kits ; sensitivity ; specificity ; Medicine ; R
    Subject code 150
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher The Pan African Medical Journal
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top